H3N2 homeopathic influenza virus solution modifies cellular and biochemical aspects of MDCK and J774G8 cell lines

Homeopathy

Volumn 102, Issue 1, 2013, Pages 31-40

  Siqueira, Camila Monteiro ^a   Costa, Beatriz ^a   Amorim, Ana Maria ^a   Gonçalves, Marta ^a   Féo da Veiga, Venício ^a   Castelo Branco, Morgana ^a   Takyia, Christina ^a   Zancan, Patrícia ^a   Câmara, Fernando Portela ^a   Couceiro, José Nelson ^a   Holandino, Carla ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Biotherapy; Human flu; J774G8 cell; MDCK cell

Indexed keywords

6 PHOSPHOFRUCTOKINASE; ANTIVIRUS AGENT; INFLUENZINUM RC; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOLOGICAL THERAPY; BIOSAFETY; CELL ACTIVITY; CELL STRUCTURE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; DRUG POTENCY; ENZYME ACTIVITY; IN VITRO STUDY; INFLUENZA A (H3N2); INFLUENZA VIRUS A H3N2; MDCK CELL; MITOCHONDRION; MITOSIS; NONHUMAN; VIRUS PARTICLE;

ANIMALS; BIOLOGICAL THERAPY; CELL LINE; DOGS; HOMEOPATHY; INDICATOR DILUTION TECHNIQUES; INFLUENZA A VIRUS, H3N2 SUBTYPE; MACROPHAGES; MICROSCOPY, ELECTRON; MITOSIS; PHOSPHOFRUCTOKINASE-1; SOLUTIONS; SPECTROPHOTOMETRY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84871859193     PISSN: 14754916     EISSN: 14764245     Source Type: Journal    
DOI: 10.1016/j.homp.2012.10.003     Document Type: Article

References (63)

1. http://www.who.int/topics/influenza/en/.
2. http://www.who.int/entity/csr/disease/swineflu/en.
3. http://http//new.paho.org/hq/index.php%3foption%3dcom_content%26task%3dview%26id%3d3154%26Item%20id%20%3d%202498%26lang%3denlink.
4. Hayden F.G. Antivirals for influenza: historical perspectives and lessons learned. Antivir Res 2006, 71(2-3):372-378.
5. Monto A.S., McKimm-Breschkin J.L., Macken C., et al. Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Antimicrob Agents Chemother 2006, 50(7):2395-2402.
6. Prober C.G. Antiviral therapy for influenza virus infection. Semin Pediatr Infect Dis 2002, 13:31-39.
7. Forleo-Neto E., Halker E., Santos V.J., Paiva T.M., Toniolo-Neto J. Influenza. Rev Soc Bras Med Trop 2003, 36(2):267-274.
8. Gomes M.L., Macedo A.M., Pena S.D., Chiari E. Genetic relationships between Trypanosoma cruzi strains isolated from chronic patients in southern Brazil as revealed by RAPD and SSR-PCR analysis. Acta Trop 1998, 69(2):99-109.
9. Gomes M.L., Macedo A.M., Vago A.R., Pena S.D., Galvão L.M., Chiari E. Trypanosoma cruzi: optimization of polymerase chain reaction for detection in human blood. Exp Parasitol 1998, 88:28-33.
10. Almeida R.L., Campos M.C., Herrera H.M., Bonamin L.V., da Fonseca A.H. Effects of homeopathy in mice experimentally infected with Trypanosoma cruzi. Homeopathy 2008, 97(2):65-69.
11. Queiroz A.O., Xavier S.C.C., Faria K.G., Bernardo R.R., Leitão T.C.A. Avaliação do bioterápico Trypanosoma cruzi 30 DH: Um Estudo In Vivo. Cult Homeopát 2006, 17:9-13.
12. Silva A.M.C.P., Schwartz F.F., Cardoso M.V., César A.T., Sollero P.A. Uso de bioterápico de Mycoplasma spp. em rebanho bovino leiteiro. Cult Homaopát 2005, 4(13):43-47.
13. Brener Z., Andrade Z.A., Netto M.B. Trypanosoma cruzi e doença de Chagas 2000, Guanabara Koogan, Rio de Janeiro, p. 431. 2nd edn.
14. Costa B.G.B., Siqueira C.M., Aquino C.L., et al. Development of a new biotherapy of Candida albicans to the treatment of oral candidiasis. 63rd Congress of the Liga Medicorum Homeopathica Internationalis (LMHI) 2008, 63:1-8.
15. Aquino C.L., Barbosa G.M., Barbosa G.M., et al. High dilutions of Euphorbia tirucalli L. (AVELOZ) modify the viability and glycolytic metabolism of cell lines. Int J High Dilution Res 2008, 7:132-139.
16. Varricchio M.C.B.N., Pereira C., Gomes T., et al. Chronic toxicological effects of high diluted solutions of Aveloz (Euphorbia tirucalli L.) on healthy mice: a preliminary study. Int J High Dilution Res 2008, 7(25):174-178.
17. Aleixo D.L., Ferraz F.N., de Melo C.S., et al. Changes of RAPD profiles of Trypanosoma cruzi II with Canova and Benznidazole. Homeopathy 2008, 97:59-64.
18. Cavalcanti A.M., Rocha L.M., Carillo R., Lima L.U., Lugon J.R. Effects of homeopathic treatment on pruritus of haemodialysis patients: a randomised placebo-controlled double-blind trial. Homeopathy 2003, 92(4):177-181.
19. Ferley J.P., Zmirou D., D'Adhemar D., Balducci F. A controlled evaluation of a homoeopathic preparation in the treatment of influenza like syndromes. Br J Clin Pharmacol 1989, 27:329-335.
20. Papp R., Schuback G., Beck E., et al. Oscillococcinum in patients with influenza-like syndromes: a placebo-controlled double-blind evaluation. Br Homeopath J 1998, 87:69-76.
21. Farmacopéia Homeopática Brasileira 2011, Ministério da Saúde, Brasil. 3rd edn.
22. Clausen J., van Wijk R., Albrecht H. Infection models in basic research on homeopathy. Homeopathy 2010 Oct, 99(4):263-270.
23. Ferraz F.N., Simoni G.K., do Nascimento A., et al. Different forms of administration of biotherapy 7dH in mice experimentally infected by Trypanosoma cruzi produce different effects. Homeopathy 2011 Oct, 100(4):237-243.
24. Vickers, Smith Homeopathic oscillococcinum for preventing and treating influenza and influenza-like syndromes. Cochrane Database Syst Rev 2006, 3.
25. Fontes O.L., Severino P., Chaud M.V., et al. Ação terapêutica do medicamento homeopático em ratas com infecção urinária por Escherichia coli. Cult Hom 2005, 13:9-18.
26. Costa R.A. Homeopathies atualizada 1988, Ed Vozes, Petrópolis, p. 268. 3rd edn.
27. Costa R.A. Nosódios Vivos 2002, Farmácia Homeopática átomo Ltda., Rio de Janeiro, p. 95. 1st edn.
28. Barros J.J.F., Alvianoc D.S., da Silva M.H., et al. Characterization of sialidase from an influenza A (H3N2) virus strain: kinetic parameters and substrate specificity. Intervirology 2003, 46:199-206.
29. Holandino C., Veiga V.F., Rodrigues M.L., Morales M.M., Capella M.A.M., Alviano C.S. Direct current decreases cell viability but not P-glycoprotein expression and function in human multidrug resistant leukaemic cell. Bioelectromagnetics 2001, 22:470-478.
30. Finter N.B. Dye uptake methods for assessing viral cytopathogenicity and their application to interferon assays. J Gen Virol 1969, 5:419-427.
31. Rogero S.O., Lugão A.B., Ikeda T.I., Cruz A.S. Teste in vitro de Citotoxicidade: estudo comparativo entre duas metodologias. Mater Res 2003, 6(3):317-320.
32. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65(1,2):55-63.
33. Veiga V.F., Nimrichter L., Teixeira C.A., et al. Exposure of human leukemic cells to direct electric current: generation of toxic compounds inducing cell death by different mechanisms. Cell Biochem Biophys 2005, 42:61-74.
34. Muehlbauer P.A., Schuler M.J. Measuring the mitotic index in chemically-treated human lymphocyte cultures by flow cytometry. Mutat Res 2003, 537:117-130.
35. Weller P.F., Dvorak A.M. Lipid bodies: intracellular sites for eicosanoid formation. J Allergy Clin Immunol 1994, 94:1151-1156.
36. Martin S., Parton R.G. Caveolin, cholesterol and lipid bodies. Cell Dev Biol 2005, 16:163-174.
37. Prophet E.B., Mills R. Laboratory methods in histotechnology 1994, Ed. American Registry of Pathology, Armed Forces Institute of Pathology, Washington, p. 279.
38. Coelho W.S., Costa K.C., Sola-Penna M. Serotonin stimulates mouse skeletal muscle 6-phosphofruto-1-kinase through tyrosine-phosphorylation of the enzyme altering its intracellular localization. Mol Genet Metab 2007, 92:364-370.
39. Wells M.A., Albrecht P., Sylvester D., Francis A.E. Host defense mechanisms against influenza virus: interaction of influenza virus with murine macrophages in vitro. Infect Immun 1978, 22(3):758-762.
40. Coligan J.E. Current Protocols in Immunology, 1, chap. 6 1995, John Wiley & Sons, Inc.
41. Bildet J., Guyot M., Bonini F., Grignon M.C., Poitevin B., Quilichini R. The effect of dilutions of Apis mellifica and Apium virus on ultraviolet light-induced erythema in the guinea pig. Ann Pharm Fr 1989, 47(1):24-32.
42. Bonamim L.V., Martinho K.S., Nina A.L., Caviglia F., Do Rio R.G. Very high dilutions of dexamethasone inhibit its pharmacological effects in vivo. Br Homeopath J 2001, 90(4):198-203.
43. Poitevein B., Davenas E., Benveniste J. In vitro immunological degranulation of human basophils is modulated by lung histamine and Apis mellifica. Br J Clin Pharmacol 1998, 25(4):439-444.
44. Mesquita L.P. Homeopathy and physiotherapy with special reference to osteoarthropathy. Br Homeopath J 1998, 76(1):16-18.
45. Witt C.M., Bluth M., Albrecht H., et al. The in vitro evidence for an effect of high homeopathic potencies - a systematic review of the literature. Complement Ther Med 2007, 15:128-138.
46. Marques R.M., Cavalca P.A.M., Casali V.W.D., Bonato C.M. Efeito de medicamentos homeopáticos na germinação de sementes de soja. Encontro Internacional de Produção Científica Cesumar (VI EPCC) 2009, Centro Universitário de Maringá.
47. -23: a bibliometric study. Homeopathy 2010, 99:25-36.
48. Elia V., Baiano S., Duro I., et al. Permanent physical chemistry properties of extremely diluted aqueous solutions of homeopathic medicines. Homeopathy 2004, 93:144-150.
49. Elia V., Marchese M., Montanino M., et al. Hydrohysteretic phenomena of extremely diluted solutions induced by mechanical treatments: a calorimetric and conductometric study at 25°C. J Solut Chem 2005, 34(8):947-960.
50. Elia V., Elia L., Cacace P., et al. The extremely diluted solutions as multi-variable systems: a study of calorimetric and conductometric behaviour as a function of the parameter time. J Therm Anal Calorim 2006, 84(2):317-323.
51. Elia V., Napoli E., Germano R. The "Memory of Water": an almost deciphered enigma. Dissipative structures in extremely dilute aqueous solutions. Homeopathy 2007, 96:163-169.
52. Rey L. Thermoluminescence of ultra high dilutions of lithium chloride and sodium chloride. Physica A 2003, 323:67-74.
53. Van Wijk R., Bosman S., Van Wijk E.P. Thermoluminescence in ultra-high dilution research. J Altern Complement Med 2006, 12(5):437-443.
54. Lobyshev V.I., Shikhlinskaya R.E., Ryzhikov B.D. Experimental evidence for intrinsic luminescence of water. J Mol Liq 1999, 82:73-81.
55. Samal S., Geckeler K.E. Unexpected solute aggregation in water on dilution. Chem Commun 2001, 21:2224-2225.
56. Walach H., Van Asseldonk T., Bourkas P., et al. Electric measurement of ultra-high dilutions - a blinded controlled experiment. Br Homeopath J 1988, 87:3-12. http://www.sciencedirect.com/science/article/pii/S0007078598800033-fn2.
57. Klimek W., Yan Y., Tschulakow A.V. A new approach to the memory of water. Homeopathy 2005, 94:241-247.
58. Rao M.L., Roy R., Bell I.R., Hoover R. The defining role of structure (including eptiaxy) in the plausibility of homeopathy. Homeopathy 2007, 96:175-182.
59. Meira D.D., Marinho-Carvalho M.M., Teixeira C.A.A., et al. Clotrimazole decreases the viability of MCF-7 human breast cancer cells through alteration of cytoskeleton morphology and cytoskeleton associated glycolytic enzymes. Mol Genet Metab 2005, 84:354-362.
60. El-Bacha T., de Freitas M.S., Sola-Penna M. Cellular distribution of phosphofructokinase activity and implications to metabolic regulation in human breast cancer. Molecular Genetics and Metabolism 2003, 79:294-299.
61. Oliveira C.C., de Oliveira S.M., Godoy L.M., Gabardo J., Buchi Dde F. Canova, a Brazilian medical formulation, alters oxidative metabolism of mice macrophages. J Infect 2006, 52:420-432.
62. Danninger T., Gallenberger K., Kraeling J. Immunologic changes in healthy probands and HIV infected patients after oral administration of Staphylococcus aureus 12C: a pilot study. Br Homeopath J 2000, 89:106-115.
63. Guimarães F.S.F., Andrade L.F., Martins S., et al. In vitro and in vivo anticancer properties of a Calcarea carbonica derivative complex (M8) treatment in a murine melanoma model. BMC Cancer 2010, 10:113.